Measurement of 3-O-methyldopa from dried plasma microsamples by high-resolution mass spectrometry: A tool for the diagnosis of patients with high-risk neuroblastoma
3-OMD is confirmed as an interesting biomarker of high-risk NB. The described method is an added value for further prospective studies involving multiple sites. The stability of 3-OMD in DPS allows for easy shipment and storage at room temperature.
Authors
- Martina Morini (ORCID: https://orcid.org/0000-0003-2569-4515)
- Alessia Cafaro (ORCID: https://orcid.org/0000-0003-1132-1267)
- Lorenzo Rossi (ORCID: https://orcid.org/0000-0001-8612-292X)
- Fabrizio Mancin (ORCID: https://orcid.org/0000-0003-0786-0364)
- Giuliana Cangemi (ORCID: https://orcid.org/0000-0001-6847-5983)
- Massimo Conte (ORCID: https://orcid.org/0000-0001-9405-7339)
- Sebastiano Barco (ORCID: https://orcid.org/0000-0002-1148-427X)
- Alberto Garaventa (ORCID: https://orcid.org/0000-0002-5368-6363)
- Davide Cangelosi (ORCID: https://orcid.org/0000-0002-6010-5619)
- Federica Pigliasco (ORCID: https://orcid.org/0000-0002-2631-8610)
- Margherita Biondi
Institutions
- University of Padua (IT)
- Istituto Giannina Gaslini (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Clinica Chimica Acta
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1016/j.cca.2024.120005
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00